Related references
Note: Only part of the references are listed.Sphere formation reverses the metastatic and cancer stem cell phenotype of the murine mammary tumour 4T1, independently of the putative cancer stem cell marker Sca-1
Heli Matilainen et al.
CANCER LETTERS (2012)
Increased Expression of P-Glycoprotein Is Associated with Doxorubicin Chemoresistance in the Metastatic 4T1 Breast Cancer Model
Lili Bao et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Haemotoxicity of busulphan, doxorubicin, cisplatin and cyclophosphamide in the female BALB/c mouse using a brief regimen of drug administration
Gemma Molyneux et al.
CELL BIOLOGY AND TOXICOLOGY (2011)
Oncolytic Herpes Simplex Virus 1 Encoding 15-Prostaglandin Dehydrogenase Mitigates Immune Suppression and Reduces Ectopic Primary and Metastatic Breast Cancer in Mice
Jason D. Walker et al.
JOURNAL OF VIROLOGY (2011)
Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
Howard L. Kaufman et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer
Ran-Ju Kim et al.
CANCER LETTERS (2010)
High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer
Christel van den Hoogen et al.
CANCER RESEARCH (2010)
Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?
Ryuichi Kanai et al.
FUTURE ONCOLOGY (2010)
SINGLE-MARKER IDENTIFICATION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA CANCER STEM CELLS WITH ALDEHYDE DEHYDROGENASE
Matthew R. Clay et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)
Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models
Abhik Bandyopadhyay et al.
PLOS ONE (2010)
High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition
Ola Awad et al.
PLOS ONE (2010)
Thalidomide suppressed the growth of 4T1 cells into solid tumors in Balb/c mice in a combination therapy with the oncolytic fusogenic HSV-1 OncdSyn
Anna Israyelyan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Aldehyde Dehydrogenase-Expressing Colon Stem Cells Contribute to Tumorigenesis in the Transition from Colitis to Cancer
Joseph E. Carpentino et al.
CANCER RESEARCH (2009)
Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
Hiroaki Wakimoto et al.
CANCER RESEARCH (2009)
Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
Emina H. Huang et al.
CANCER RESEARCH (2009)
Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
Nikolaos A. Dallas et al.
CANCER RESEARCH (2009)
Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes
Dan Ran et al.
EXPERIMENTAL HEMATOLOGY (2009)
Engineered herpes simplex viruses efficiently infect and kill CD133+human glioma xenograft cells that express CD111
Gregory K. Friedman et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
Feng Jiang et al.
MOLECULAR CANCER RESEARCH (2009)
A Combined Chemoimmunotherapy Approach Using a Plasmid-Doxorubicin Complex
Vaishali Bagalkot et al.
MOLECULAR PHARMACEUTICS (2009)
Targeting Cancer-initiating Cells With Oncolytic Viruses
Timothy P. Cripe et al.
MOLECULAR THERAPY (2009)
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
A. Soeda et al.
ONCOGENE (2009)
Neuroblastoma Cell Lines Contain Pluripotent Tumor Initiating Cells That Are Susceptible to a Targeted Oncolytic Virus
Yonatan Y. Mahller et al.
PLOS ONE (2009)
CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors
Dagmar Beier et al.
BRAIN PATHOLOGY (2008)
Virotherapy as an approach against cancer stem cells
Camilla Ribacka et al.
CURRENT GENE THERAPY (2008)
Cancer stem cells: implications for the progression and treatment of metastatic disease
A. K. Croker et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy
Madhuri Kakarala et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties
Vera Levina et al.
PLOS ONE (2008)
Herpes simplex virus type-I (HSV-I) oncolytic and highly fusogenic mutants carrying the NV1020 genomic deletion effectively inhibit primary and metastatic tumors in mice
Anna Israyelyan et al.
VIROLOGY JOURNAL (2008)
Armed oncolytic herpes simplex viruses for brain tumor therapy
Tomoki Todo
CELL ADHESION & MIGRATION (2008)
Identification and localization of a putative ATP-binding cassette transporter in sea lice (Lepeophtheirus salmonis) and host Atlantic salmon (Salmo salar)
N. D. Tribble et al.
PARASITOLOGY (2008)
Breast cancer stem cells: implications for therapy of breast cancer
Brian J. Morrison et al.
BREAST CANCER RESEARCH (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Induction of strong antitumor immunity by an HSV-2-based oncolytic virus in a murine mammary tumor model
Hongtao Li et al.
JOURNAL OF GENE MEDICINE (2007)
Oncolytic herpes simplex virus type 1 and host immune responses
Hiroshi Fukuhara et al.
CURRENT CANCER DRUG TARGETS (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Characterization of stem cell-like cancer cells in immune-competent mice
Jorg A. Kruger et al.
BLOOD (2006)
Efficacy of oncolytic herpesvirus NV1020 can be enhanced by combination with chemotherapeutics in colon carcinoma cells
Anja Gutermann et al.
HUMAN GENE THERAPY (2006)
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor
Jennifer C. C. Hu et al.
CLINICAL CANCER RESEARCH (2006)
Mechanisms of disease - Cancer stem cells
Craig T. Jordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
Giulia Fulci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication
M Aghi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Recent progress in the battle between oncolytic viruses and tumours
KA Parato et al.
NATURE REVIEWS CANCER (2005)
A novel assay for assessment of HIV-specific cytotoxicity by multiparameter flow cytometry
K Godoy-Ramirez et al.
CYTOMETRY PART A (2005)
The Sca-1 cell surface marker enriches for a prostateregenerating cell subpopulation that can initiate prostate tumorigenesis
L Xin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Treatment of mice with anti-CD86 mAb reduces CD8+ T cell-mediated CTL activity and enhances ocular viral replication in HSV-1-infected mice
Y Osorio et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2005)
Effect of small-sized liposomal Adriamycin administered by various routes on a metastatic breast cancer model
JH Chen et al.
ENDOCRINE-RELATED CANCER (2005)
Treatment of solid sarcomas in immunocompetent mice with novel, oncolytic herpes simplex viruses
S Sugiura et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2004)
A distinct side population of cells with high drug efflux capacity in human tumor cells
C Hirschmann-Jax et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Destruction of nonimmunogenic mammary tumor cells by a fusogenic oncolytic herpes simplex virus induces potent antitumor immunity
M Nakamori et al.
MOLECULAR THERAPY (2004)
Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials
SM Swain et al.
CANCER (2003)
Preclinical evaluation of DISC-GMCSF for the treatment of breast carcinoma
PT Loudon et al.
JOURNAL OF GENE MEDICINE (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
BL Liu et al.
GENE THERAPY (2003)
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
T Todo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
